Jean-Michel Gracies Selected Research

Paresis (Hemiparesis)

1/2021	The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury.
1/2021	Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.
1/2021	When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
1/2020	Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies.
1/2020	Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial.
10/2019	Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis.
3/2019	Guided Self-rehabilitation Contract vs conventional therapy in chronic stroke-induced hemiparesis: NEURORESTORE, a multicenter randomized controlled trial.
1/2019	Ultrasound Structural Changes in Triceps Surae After a 1-Year Daily Self-stretch Program: A Prospective Randomized Controlled Trial in Chronic Hemiparesis.
11/2018	Evolution of upper limb kinematics four years after subacute robot-assisted rehabilitation in stroke patients.
10/2018	Botulinum Toxin Injections and Electrical Stimulation for Spastic Paresis Improve Active Hand Function Following Stroke.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Michel Gracies Research Topics

Disease

19	Paresis (Hemiparesis) 01/2021 - 05/2005
13	Muscle Spasticity (Spastic) 01/2021 - 03/2004
12	Stroke (Strokes) 01/2021 - 10/2002
6	Parkinson Disease (Parkinson's Disease) 09/2017 - 07/2004
3	Brain Injuries (Brain Injury) 10/2019 - 01/2009
3	Dyskinesias (Dyskinesia) 02/2009 - 07/2004
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 10/2015
2	Pain (Aches) 10/2015 - 09/2012
2	Tremor (Tremors) 05/2008 - 07/2002
1	Infections 01/2021
1	COVID-19 01/2021
1	Torticollis (Wryneck) 01/2020
1	Cognitive Dysfunction 01/2015
1	Spasm (Spasms) 09/2012
1	Parkinsonian Disorders (Parkinsonism) 11/2008
1	Dementia (Dementias) 11/2008
1	Movement Disorders (Movement Disorder) 05/2008
1	Myoclonus (Nocturnal Myoclonus) 05/2008
1	Dystonia (Limb Dystonia) 05/2008
1	Paralysis (Palsy) 03/2004

Drug/Important Bio-Agent (IBA)

9	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 03/2004
9	abobotulinumtoxinA FDA Link 01/2021 - 10/2015
6	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 01/2009
3	Levodopa (L Dopa)FDA LinkGeneric 09/2017 - 07/2004
2	amsonic acid (DAS)IBA 10/2015 - 10/2002
1	Therapeutic UsesIBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2017
1	Prostaglandins AIBA 10/2015
1	rimabotulinumtoxinB FDA Link 07/2014
1	Dopamine (Intropin)FDA LinkGeneric 08/2011
1	Pharmaceutical PreparationsIBA 05/2008
1	PlasticsIBA 05/2005

Therapy/Procedure

8	Injections 01/2021 - 01/2009
7	Therapeutics 01/2021 - 03/2004
2	Activities of Daily Living (ADL) 01/2021 - 07/2002
2	Occupational Therapy (Therapy, Occupational) 11/2018 - 10/2017
2	Deep Brain Stimulation 09/2017 - 07/2004
2	Physical Therapy Modalities (Physical Therapy Technique) 01/2017 - 01/2007
2	Home Nursing (Nursing, Home) 11/2008 - 05/2008
1	Subacute Care 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Retreatment 01/2020
1	Transplantation 02/2009
1	Polypharmacy 11/2008